首页 > 抗体蛋白 > 抗体
PE anti-mouse Ly-6A/E (Sca-1) Antibody
产品名称:
PE anti-mouse Ly-6A/E (Sca-1) Antibody
产品类别:
抗体
产品编号:
108107
产品应用:
108107
[价格]
规格 价格 库存
50µg ¥ 1708 1

产品详情

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
IL-2-dependent mouse T-cell line (CTL-L)
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.5 ?g per million cells in 100 ?l volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

The D7 antibody has been reported to induce T cell activation and inhibit TCR-induced IL-2 production. Additional reported applications (for the relevant formats) include: Western blotting1,2, immunoprecipitation1, in vitro lymphocyte activation3-6, induction of redirected lysis7, induction of T cell inhibitory signalling8, immunofluorescence9, and immunohistochemical staining of acetone-fixed frozen sections13 and Bouin-fixed,?paraffin-embedded samples9.

The two Sca-1 recognizing clones?D7?and E13-161.7 have been shown to bind distinct epitopes due to the inability of D7 to block the binding of E13-161.7.14?

Application References

(PubMed link indicates BioLegend citation)
  1. Ortega G, et al. 1986. J. Immunol. 137:3240. (WB, IP)
  2. Palfree RGE, et al. 1986. Immunogenetics 23:197. (WB)
  3. Codias EK, et al. 1990. J. Immunol. 144:2197.
  4. Malek TR, et al. 1986. J. Exp. Med. 164:709.
  5. Codias EK, et al. 1990. J. Immunol. 145:1407.
  6. Ivanov V, et al. 1994. J. Immunol. 153:2394.
  7. Karlhofer FM, et al. 1991. J. Immunol. 146:3662.
  8. Fleming T, et al. 1994. J. Immunol. 153:1955.
  9. van Bragt MPA, et al. 2005. Biol. Reprod. 73:634. (IF, IHC)
  10. Umland O, et al. 2007. J. Immunol. 178:4147.
  11. Cridland SO, et al. 2009. Blood Cell. Mol. Dis. 45:149. (FC) PubMed
  12. Pronk CJ, et al. 2011. J. Exp Med. PubMed
  13. English A, et al. 2000. J. Immunol. 165:3763. (IHC)
  14. Bamezai A and Rock KL. 1995. Proc. Natl. Acad. Sci. USA 92:4294.
  15. Wiesner DL, et al. 2015. PLoS Pathog. 11:1004701. PubMed
Product Citations
  1. Hutter K, et al. 2022. Front Immunol. 13:967914. PubMed
  2. Perveen S, et al. 2012. PLoS One. 7:e51945. PubMed
  3. Tran NT, et al. 2019. Cell Rep. 28:3510. PubMed
  4. Enquist I, et al. 2009. Stem Cells. 27:744. PubMed
  5. Wang L, et al. 2020. Cell Metab. 32:860. PubMed
  6. Yang M, et al. 2020. Cell Prolif. 53:e12784. PubMed
  7. Li J, et al. 2022. Int J Biol Sci. 18:2091. PubMed
  8. Cui Z, et al. 2022. Bone Res. 10:58. PubMed
  9. Sieveking D, et al. 2010. J Exp Med. 207:345. PubMed
  10. Wu R, et al. 2019. J Cell Mol Med. 24:1684. PubMed
  11. Vannini N, et al. 2019. Cell Stem Cell. 24:405. PubMed
  12. Yoshida K, et al. 2022. Sci Rep. 12:17276. PubMed
  13. Li J, et al. 2019. JCI Insight. 5. PubMed
  14. Shimokawa C et al. 2017. Immunity. 46(5):863-874 . PubMed
  15. Flommersfeld S, et al. 2021. Immunity. :. PubMed
  16. Phan QM, et al. 2020. Elife. 9:00. PubMed
  17. Maluski M, et al. 2019. J Clin Invest. 129:5108. PubMed
  18. Marinescu CI, et al. 2021. Stem Cell Res Ther. 12:319. PubMed
  19. Lu X, et al. 2016. Nat Commun. 7: 12719. PubMed
  20. Zhao J, et al. 2018. Stem Cell Reports. 10:180. PubMed
  21. Hu Y, et al. 2021. Bioact Mater. 2905:6. PubMed
  22. Oka Y, et al. 2020. Sci Adv. 6:. PubMed
  23. Wang X, et al. 2018. Cell Death Dis. 9:578. PubMed
  24. LaFleur MW, et al. 2019. Nat Commun. 10:1668. PubMed
  25. Chen Z, et al. 2019. J Exp Med. 216:152. PubMed
  26. Xu X, et al. 2022. EMBO Rep. 23:e53509. PubMed
  27. Gao Y, et al. 2020. Immunity. 52(6):1007-1021.e8. PubMed
  28. N. H, et al. 2017. Journal of Vascular Research. 10.1159/000464287. PubMed
  29. Sun J et al. 2018. Cell stem cell. 23(3):355-369 . PubMed
  30. Li CJ, et al. 2018. J Clin Invest. 128:5251. PubMed
  31. Hou J, et al. 2017. Mol Med Rep. 16:1502. PubMed
  32. Nowlan B, et al. 2019. Haematologica. 105:71. PubMed
  33. Ha TC, et al. 2020. Hum Gene Ther. 32:458. PubMed
  34. Zelco A, et al. 2020. Front Cell Neurosci. 0.75625. PubMed
  35. Schw?rer S, et al. 2016. Nature. 540:428-432. PubMed
  36. Rüder C, et al. 2014. PLoS One. 9:104644. PubMed
  37. Kwiecien K, et al. 2020. Sci Rep. 10:13702. PubMed
  38. Bruno C, et al. 2020. Brain Commun. 2:fcaa133. PubMed
  39. Miura Y et al. 2018. eLife. 7 pii: e36572. PubMed
  40. Ge Q, et al. 2018. Mol Med Rep. 17:1667. PubMed
  41. Golan K et al. 2018. Cell stem cell. 23(4):572-585 . PubMed
  42. Kopinke D et al. 2017. Cell. 170(2):340-351 . PubMed
  43. Li ZG, et al. 2020. Chin Med J (Engl). 1943:133. PubMed
  44. Li Z et al. 2018. Immunity. 49(4):640-653 . PubMed
  45. Young K, et al. 2021. Cell Stem Cell. . PubMed
RRID
AB_313344 (BioLegend Cat. No. 108107) AB_313345 (BioLegend Cat. No. 108108)

Antigen Details

Structure
Ly-6 multigene family, 18 kD
Distribution

Hematopoietic stem cells, activated T cells and B cells, subset of resting B cells and T cells

Function
Regulates B and T cell responses
Cell Type
B cells, Hematopoietic stem and progenitors, Mesenchymal Stem Cells, T cells
Biology Area
Immunology, Stem Cells
Antigen References

1. Rock KL, et al. 1989. Immunol. Rev. 111:195.
2. Morrison SJ, et al. 1994. Immunity 1:661.
3. Spangrude GJ, et al. 1988. J. Immunol. 141:3697.
4. Malek T, et al. 1986. J. Exp. Med. 164:709.

Gene ID
110454 View all products for this Gene ID
UniProt
View information about Ly-6A/E on UniProt.org

联系我们

TEL:021-34661275  点击拨打热线